Breast Radiotherapy: Less is More?

被引:25
作者
Coles, C. E. [1 ]
Brunt, A. M. [2 ]
Wheatley, D. [3 ]
Mukesh, M. B. [1 ]
Yarnold, J. R. [4 ,5 ]
机构
[1] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England
[2] Univ Hosp N Staffordshire NHS Trust, Stoke On Trent, Staffs, England
[3] Royal Cornwall Hosp NHS Trust, Truro, England
[4] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[5] Inst Canc Res, Sutton, Surrey, England
基金
英国医学研究理事会;
关键词
Breast cancer; clinical trials; radiotherapy; TARGETED INTRAOPERATIVE RADIOTHERAPY; CONSERVING THERAPY; WHOLE-BREAST; HYPOFRACTIONATED RADIOTHERAPY; UK STANDARDIZATION; RADIATION-THERAPY; SURGICAL CLIPS; DOSE-RESPONSE; NORMAL TISSUE; CANCER;
D O I
10.1016/j.clon.2012.10.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 3 week schedule of whole breast radiotherapy is firmly established in the UK and is becoming more accepted internationally, especially as accelerated partial breast radiotherapy regimens become more common. It seems that a 3 week schedule is unlikely to be the lower limit of whole breast hypofractionation and the partial breast may even be adequately treated with just a single treatment. It is, however, essential that these hypotheses are rigorously tested within well-designed trials to ensure the highest quality of radiotherapy. This overview will address the rationale for hypofractionation in breast cancer, discuss past trials and outline the design of current studies. (c) 2012 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 50 条
  • [41] Second breast conserving surgery and interstitial radiotherapy for the treatment of breast tumor local recurrences
    Viktor, Smanyko
    Meszaros Norbert
    Ujhelyi Mihaly
    Frohlich Georgina
    Stelczer Gabor
    Major Tibor
    Matrai Zoltan
    Polgar Csaba
    ORVOSI HETILAP, 2018, 159 (11) : 430 - 438
  • [42] Robustness of hypofractionated breast radiotherapy after breast-conserving surgery with free breathing
    Chen, Kunzhi
    Sun, Wuji
    Han, Tao
    Yan, Lei
    Sun, Minghui
    Xia, Wenming
    Wang, Libo
    Shi, Yinghua
    Ge, Chao
    Yang, Xu
    Li, Yu
    Wang, Huidong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [43] Personalized Approaches to Breast Radiotherapy: Strategies for Treatment Refinement
    O'Brien, Diana A. Roth
    Braunstein, Lior Z.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (01) : 30 - 39
  • [44] Pushing the limits of hypofractionation for adjuvant whole breast radiotherapy
    Yarnold, John
    Haviland, Joanne
    BREAST, 2010, 19 (03) : 176 - 179
  • [45] Dosimetric absorption of intensity-modulated radiotherapy compared with conventional radiotherapy in breast-conserving surgery
    Lin, Yang
    Wang, Benzhong
    ONCOLOGY LETTERS, 2015, 9 (01) : 9 - 14
  • [46] Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials
    Housri, Nadine
    Khan, Atif J.
    Taunk, Neil
    Goyal, Sharad
    Nelson, Carl J.
    Ferro, Adam
    Haffty, Bruce G.
    BREAST JOURNAL, 2015, 21 (04) : 387 - 394
  • [47] Particle radiotherapy for breast cancer
    Ruan, Hanguang
    Okamoto, Masahiko
    Ohno, Tatsuya
    Li, Yang
    Zhou, Yuan
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [48] Advances in Radiotherapy for Breast Cancer
    Upadhyay, Rituraj
    Bazan, Jose G.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (03) : 515 - 536
  • [49] Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
    Aly, Moamen M. O. M.
    Glatting, Gerhard
    Jahnke, Lennart
    Wenz, Frederik
    Abo-Madyan, Yasser
    RADIATION ONCOLOGY, 2015, 10
  • [50] Adaptive radiotherapy for breast cancer
    De-Colle, C.
    Kirby, A.
    Russell, N.
    Shaitelman, S. F.
    Currey, A.
    Donovan, E.
    Hahn, E.
    Han, K.
    Anandadas, C. N.
    Mahmood, F.
    Lorenzen, E. L.
    van den Bongard, D.
    Koerkamp, M. L. Groot
    Houweling, A. C.
    Nachbar, M.
    Thorwarth, D.
    Zips, D.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 39